Guru Ownership Over Time
Guru Analysis for BridgeBio Pharma, Inc. (BBIO)
BridgeBio Pharma, Inc. (BBIO), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q3 2025, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.24 B.
Top institutional holders include Andreas Halvorsen and Renaissance Technologies.
Institutional sentiment is currently Bearish. This is evidenced by a $137.78 M net outflow during the quarter.
Recent activity highlights Renaissance Technologies who increased their stake by 31.0%. Conversely, Cliff Asness reduced exposure by 37.4%.
| Portfolio Manager | % of portfolio | Activity | Shares | Value | Peroid |
|---|---|---|---|---|---|
| 2.16% | Reduce -13.9% | 15,977,849 | $829.89 M | Q3 2025 | |
| 0.02% | Add 31.0% | 322,246 | $16.74 M | Q3 2025 | |
| 0.12% | Add 4.8% | 232,923 | $12.1 M | Q3 2025 | |
| 0.00% | Reduce -37.4% | 98,827 | $5.13 M | Q3 2025 |
| Period | Portfolio Manager | Activity | Share change | % change to portfolio |
|---|
| Period | Portfolio Manager | Activity | Share change | % change to portfolio |
|---|
| Period | Portfolio Manager | Activity | Share change | % change to portfolio |
|---|
| Portfolio Manager | Option Type | % of portfolio | Activity | Shares | Value | Period |
|---|
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown(Q3 2025)
Guru Consensus (Q3 2025)
FAQs for BridgeBio Pharma, Inc. (BBIO)
Top Guru holders include Andreas Halvorsen ($829.89 M), Renaissance Technologies ($16.74 M), Chuck Royce ($12.1 M). Collectively, tracked Gurus hold 16.63 M shares.
Based on recent 13F filings, the sentiment is **Negative (Net Sell)**. There was a net outflow of $137.78 M, with 2 Gurus buying and 3 Gurus selling.
In the recent quarter, 2 Gurus reduced their positions, and 1 Gurus sold out of BBIO completely. Total sell value was $142.3 M.
Yes, 0 Gurus opened new positions in BBIO, and 2 added to their existing holdings. Total buy value was $4.51 M.